The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 308.00
Ask: 308.50
Change: 14.50 (4.97%)
Spread: 0.50 (0.162%)
Open: 298.00
High: 308.00
Low: 285.50
Prev. Close: 291.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

16 May 2013 07:00

RNS Number : 8356E
Synthomer PLC
16 May 2013
 



16th May 2013

 

 

Synthomer plc

 

AGM and Interim Management Statement

 

Synthomer plc ("Synthomer" or "the Group") today issues its Interim Management Statement for the period 1 January to 16 May 2013.

 

Trading

 

After the Group's solid start to the year, demand in Europe was weaker than anticipated during March and April. While trading in Asia has been ahead of expectations in the year-to-date, volumes and profits for the Group overall were lower against a strong performance in the same period in 2012.

 

Since Synthomer's last update in March, the macro-economic environment in Europe has remained challenging and this has continued to impact demand. Our Europe and North America (ENA) business experienced 7% year-on-year volume declines in March and April. Weakness continued to be most evident in construction and related areas, in part due to the adverse weather conditions.

 

In Asia and Rest of the World, trading has been ahead of our expectations and demand across all business areas remains strong. Nitrile has outperformed our expectations and we now expect full year nitrile operating profit to be ahead of 2012. Our non-nitrile businesses have continued to trade well, with the benefits of strong demand restricted only by the capacity constraints we currently face in Asia.

 

The Group's additional 70,000 tonnes of nitrile capacity, completed at the end of 2012, is now operational, and our plans to bring SBR latex capability on stream in Malaysia during the second half of the year remain on track.

 

The Group's financial position remains robust, with net debt slightly higher over the first 4 months reflecting the higher levels of capital expenditure anticipated for the year, and the normal seasonal working capital outflow.

 

Outlook

 

Continued weakness in the macro-economic environment in Europe has resulted in challenging trading conditions for our business and, given the performance of our ENA business in March and April, we remain cautious about the outlook for the year. We are encouraged by the progress being made in our Asian business, with demand growth remaining strong and improved nitrile market dynamics. The Board expects this relative strength in Asia will partially offset the weakness being seen in Europe.

 

Synthomer will announce its Interim Results on Tuesday 13th August 2013.

 

Enquiries:

 

Adrian Whitfield, Chief Executive Officer

Charles Armitstead / Rosie Oddy

David Blackwood, Chief Financial Officer

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

The company will host a conference call for analysts at 8.00am (BST) today:

 

  Dial-In: +44 203 426 2886

Please quote "Synthomer" to gain access to the call

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUVVKROUAVAAR
Date   Source Headline
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue
7th Sep 20237:00 amRNSHalf-year results
18th Jul 20237:00 amRNSPost-close trading update
12th Jul 20233:17 pmRNSAppointment of Non-Executive Director
28th Jun 202312:37 pmRNSDirector/PDMR Shareholding
28th Jun 202312:36 pmRNSDirector/PDMR Shareholding
22nd Jun 202310:20 amRNSDirector/PDMR Shareholding
16th May 20234:00 pmRNSResult of AGM
16th May 20237:00 amRNSAGM trading update
12th May 20231:08 pmRNSDirector/PDMR Shareholding
12th May 20231:06 pmRNSDirector/PDMR Shareholding
13th Apr 202310:02 amRNSHolding(s) in Company
12th Apr 20235:52 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSRefinancing
28th Feb 20233:33 pmRNSDisposal
31st Jan 20237:00 amRNSPost-close update for the year ended 31 Dec 2022
11th Jan 202311:30 amRNSResult of General Meeting
16th Dec 202212:12 pmRNSPublication of Circular &Notice of General Meeting
13th Dec 20227:00 amRNSProposed Sale of Laminates, Films & Coated Fabrics
8th Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSBoard changes
29th Nov 202211:16 amRNSOutcome of European Commission investigation
1st Nov 20222:53 pmRNSHolding(s) in Company
27th Oct 202210:27 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSCovenant relaxation to the end of 2023 agreed
13th Oct 20227:00 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSInvestor Seminar
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 202210:40 amRNSDirector/PDMR Shareholding
4th Oct 202210:37 amRNSDirector/PDMR Shareholding
29th Sep 20227:00 amRNSTrading update
23rd Sep 20229:23 amRNSHolding(s) in Company
12th Sep 20223:27 pmRNSHolding(s) in Company
6th Sep 20228:15 amRNSHolding(s) in Company
12th Aug 20229:22 amRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
9th Aug 20224:09 pmRNSHolding(s) in Company
9th Aug 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.